| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/07/1998 | US5736510 Antibiotics 10381v, w, x,y, z1, z2, pre-b and t |
| 04/07/1998 | US5736336 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 04/07/1998 | CA2130116C Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/07/1998 | CA2066464C Preparation process of .alpha.-aspartyl-l-phenylalanine methyl ester |
| 04/04/1998 | CA2217377A1 Building blocks for dna/pna co-oligomers |
| 04/02/1998 | WO1998013460A1 Liquid detergents containing proteolytic enzyme and protease inhibitors |
| 04/02/1998 | WO1998013377A1 Cytotoxic peptides |
| 04/02/1998 | WO1998013375A1 Compounds with antimycotic and cytostatic effect, preparation method, agent containing these compounds and dsm 11 092 |
| 04/02/1998 | WO1998013061A1 Inhibition of 26s and 20s proteasome by indanones |
| 04/02/1998 | WO1998013060A1 Use of a cytokine regulatory agent to treat rheumatoid arthritis |
| 04/02/1998 | WO1998013059A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | DE19743210A1 Blade for scraping or coating applications |
| 04/02/1998 | DE19643764A1 Glycokonjugate von modifizierten Camptothecin-Derivaten (20-0-Verknüpfung) Glycoconjugates of modified camptothecin derivatives (20-0 link) |
| 04/02/1998 | DE19640207A1 Glycokonjugate von modifizierten Camptothecin-Derivaten (A- oder B-Ring-Verknüpfung) Glycoconjugates of modified camptothecin derivatives (A or B ring junction) |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2264227A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| 04/02/1998 | CA2263134A1 Cytotoxic peptides |
| 04/01/1998 | EP0832982A2 Process for the preparation of the disodium salt of z-l-aspartic acid from fumaric acid |
| 04/01/1998 | EP0832900A1 Peptide and method of obtaining it |
| 04/01/1998 | EP0832879A1 Process for preparing intermediates for thrombin inhibitors |
| 04/01/1998 | EP0832150A1 Cascade polymers with iodine-containing aromatic compounds |
| 04/01/1998 | EP0832104A1 Novel dolastatin derivatives, their preparation and use |
| 04/01/1998 | EP0832102A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa |
| 04/01/1998 | EP0832101A2 Urethane mediated, gst specific molecular release systems |
| 04/01/1998 | EP0832100A1 Novel inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
| 04/01/1998 | EP0832099A1 Reversible cysteine protease inhibitors |
| 04/01/1998 | EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals |
| 04/01/1998 | EP0832065A1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 04/01/1998 | EP0831939A1 Structurally determined metallo-constructs and applications |
| 04/01/1998 | EP0831920A1 Novel cathepsin and methods and compositions for inhibition thereof |
| 04/01/1998 | EP0831877A1 Metabolic effects of certain glutathione analogs |
| 04/01/1998 | EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1998 | US5734081 Arylthio compounds |
| 03/31/1998 | US5734049 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 03/31/1998 | US5734018 Biosynthesis detection, analyzing method to obtain peptide sequences |
| 03/31/1998 | US5734011 Ligand precursors for incorporation into peptides |
| 03/31/1998 | US5733928 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 03/31/1998 | US5733883 Crystallization of α-L-aspartyl-L-phenylalanine methyl ester from aqueous solution |
| 03/31/1998 | US5733881 Analgesics, immunosuppressants |
| 03/31/1998 | US5733880 Anthracene derivatives for use as anticancer agents |
| 03/31/1998 | US5733538 Surface-modifying copolymers having cell adhesion properties |
| 03/26/1998 | WO1998012217A1 Heterodimer peptides with immunomodulatory effect |
| 03/26/1998 | WO1998012213A2 Cysteine containing peptides |
| 03/26/1998 | WO1998012212A1 Nucleopeptide complexes, cosmetic and pharmaceutical compositions containing them and their uses |
| 03/26/1998 | WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | WO1997035990A3 Histone deacetylases, and uses related thereto |
| 03/26/1998 | DE19638870A1 Verbindungen mit antimykotischer und cytostatischer Wirkung, Herstellungsverfahren, Mittel und DSM 11 092 Compounds with antifungal and cytostatic effect, manufacturing methods, means and DSM 11092 |
| 03/26/1998 | CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/25/1998 | EP0831100A1 Novel peptide derivatives |
| 03/25/1998 | EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability |
| 03/25/1998 | EP0830371A1 IMIDAZO 1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS |
| 03/25/1998 | EP0830368A1 Novel carbamate-based cationic lipids |
| 03/25/1998 | EP0830136A1 New cryptophycins from synthesis |
| 03/24/1998 | US5731459 Process for separating amino acids and aminosulponic acids through adsorption on zeolites |
| 03/24/1998 | US5731439 Piperidine containing aminobornic acids |
| 03/24/1998 | US5731413 Liquid or solid phase biosynthesis |
| 03/24/1998 | US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
| 03/20/1998 | CA2185950A1 Process for preparing intermediates for thrombin inhibitors |
| 03/19/1998 | WO1998011129A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 03/19/1998 | WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 03/19/1998 | WO1998011126A1 Peptide prodrugs containing an alpha-hydroxyacid linker |
| 03/19/1998 | WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
| 03/19/1998 | WO1998010792A1 Immune direction therapy |
| 03/19/1998 | WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders |
| 03/19/1998 | WO1998010778A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS |
| 03/19/1998 | WO1998010651A1 Conjugates useful in the treatment of prostate cancer |
| 03/19/1998 | CA2265928A1 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 03/19/1998 | CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders |
| 03/19/1998 | CA2265476A1 Conjugates useful in the treatment of prostate cancer |
| 03/19/1998 | CA2265454A1 Peptide prodrugs containing an alpha-hydroxyacid linker |
| 03/19/1998 | CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production |
| 03/19/1998 | CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
| 03/18/1998 | EP0828851A2 Tripeptidylpeptidase inhibitors |
| 03/18/1998 | EP0828754A1 Dipeptides which promote release of growth hormone |
| 03/18/1998 | EP0563329B1 Angiogenic peptides |
| 03/18/1998 | CN1176646A CCK or gastrin modulating 5 -heterocyclic-1, 5-benzodiazepines |
| 03/18/1998 | CN1176645A Compounds with growth hormone releasing properties |
| 03/18/1998 | CN1176307A Preparation of selenic antibody enzyme with activity higher than that of natural enzyme |
| 03/17/1998 | US5728863 Process for producing α-L-aspartyl-L-phenylalanine methyl ester |
| 03/17/1998 | US5728862 From aspartame and 3,3-dimethylbutyraldehyde by hydrogenation |
| 03/17/1998 | US5728711 Antiulcer agents |
| 03/17/1998 | US5728680 Methods for normalizing numbers of lymphocytes |
| 03/17/1998 | US5728544 Useful in synthesis of aspartame intermediate |
| 03/17/1998 | CA1339756C Peptide derivatives and antidementia agents |
| 03/12/1998 | WO1998009988A1 Process to prepare pharmaceutical compounds |
| 03/12/1998 | WO1998009987A1 Lactam inhibitors of thrombin |
| 03/12/1998 | WO1998009986A1 S-blocked glutathiones |
| 03/12/1998 | WO1998009985A2 Anti-inflammatory peptides and uses thereof |
| 03/12/1998 | WO1998009984A1 Central nervous system-derived immune privilege factor and uses thereof |
| 03/12/1998 | WO1998009950A1 Process for preparing amidines |
| 03/12/1998 | WO1998009641A1 Semipeptoid farnesyl protein transferase inhibitors and analogs thereof |
| 03/12/1998 | WO1997046259A3 Chimeric toxin for targeted therapy |
| 03/12/1998 | DE19636623A1 New acyl-(aryl- or hetero-aryl(carbonyl))aminoacid compounds |
| 03/12/1998 | CA2264959A1 Central nervous system-derived immune privilege factor and uses thereof |
| 03/12/1998 | CA2264723A1 Process for preparing amidines |